Journal article · 2026
Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition
New England Journal of Medicine · Published 7 November 2026 · DOI 10.1056/nejmc2611265
In brief
“Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition” is a 2026 journal article by Morris Jonathan Brown and 10 co-authors, published in New England Journal of Medicine. OpenAlex counts 0 citations as of 16 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 5
- Authors
- 11
Abstract
Among patients with hypertension due to primary aldosteronism, reductions in blood pressure and the aldosterone-to-renin ratio persisted for 2 years after completion of an extended course of aldosterone synthase inhibition. Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Brown, M. J., Turcu, A. F., Sam, R., Kirschner, L. S., Hamidi, O., Eren, A., Ben-Shlomo, A., Huang, W., Bancos, I., Hamrahian, A. H., & Freeman, M. W. (2026). Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition. New England Journal of Medicine. https://doi.org/10.1056/nejmc2611265
MLA 9
Brown, Morris Jonathan, et al. “Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition.” New England Journal of Medicine, 2026. https://doi.org/10.1056/nejmc2611265.
Chicago
Brown, Morris Jonathan, Adina F. Turcu, Ramin Sam, Lawrence Steven Kirschner, Oksana Hamidi, Ayşegül Eren, Anat Ben-Shlomo, et al. 2026. “Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition.” New England Journal of Medicine. https://doi.org/10.1056/nejmc2611265.
Harvard
Brown, M. J. et al. (2026) ‘Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition’, New England Journal of Medicine. doi:10.1056/nejmc2611265.
IEEE
M. J. Brown et al., “Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition,” New England Journal of Medicine, 2026, doi: 10.1056/nejmc2611265.
BibTeX
@article{brown2026hyperaldosteronism,
title = {{Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition}},
author = {Brown, Morris Jonathan and Turcu, Adina F. and Sam, Ramin and Kirschner, Lawrence Steven and Hamidi, Oksana and Eren, Ayşegül and Ben-Shlomo, Anat and Huang, Wenyu and Bancos, Irina and Hamrahian, Amir Hekmat and Freeman, Mason Wright},
journal = {New England Journal of Medicine},
year = {2026},
doi = {10.1056/nejmc2611265},
url = {https://doi.org/10.1056/nejmc2611265}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- primary aldosteronism
- aldosterone synthase inhibition
- extended treatment duration
- hypertension
- aldosterone-renin ratio
- blood pressure reduction
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Brown, M. J., Turcu, A. F., Sam, R., Kirschner, L. S., Hamidi, O., Eren, A., Ben-Shlomo, A., Huang, W., Bancos, I., Hamrahian, A. H., & Freeman, M. W. (2026). Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition. New England Journal of Medicine. https://doi.org/10.1056/nejmc2611265
How many times has this paper been cited?
0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Morris Jonathan Brown, Adina F. Turcu, Ramin Sam, Lawrence Steven Kirschner, Oksana Hamidi, Ayşegül Eren, Anat Ben-Shlomo, Wenyu Huang, Irina Bancos, Amir Hekmat Hamrahian, Mason Wright Freeman.
What is the DOI of this paper?
10.1056/nejmc2611265, permanently at https://doi.org/10.1056/nejmc2611265. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.